AVP and metabolic dysfunction-associated steatotic liver disease: In conclusion, our data show for the first time a link between altered regulation of the VP system measured as elevated circulating copeptin concentration, and presence of NAFLD in the population, suggesting an completely new and potentially modifiable risk factor behind fatty liver disease.